2018
DOI: 10.3390/nano8110907
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic Alginate/Chitosan Nanoparticles for Targeted Delivery of Curcumin into Human Breast Cancer Cells

Abstract: Curcumin is a promising anti-cancer drug, but its applications in cancer therapy are limited, due to its poor solubility, short half-life and low bioavailability. In this study, curcumin loaded magnetic alginate/chitosan nanoparticles were fabricated to improve the bioavailability, uptake efficiency and cytotoxicity of curcumin to Human Caucasian Breast Adenocarcinoma cells (MDA-MB-231). Alginate and chitosan were deposited on Fe3O4 magnetic nanoparticles based on their electrostatic properties. The nanopartic… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
57
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 119 publications
(63 citation statements)
references
References 83 publications
5
57
0
1
Order By: Relevance
“…5-flurouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles 4 showed a sustained release and enhanced anti-cancer effects both in vitro and in vivo [29]. Song et al, 2018 [30] reported the high uptake efficiency, toxicity, and sustained release in human Caucasian breast adenocarcinoma cells (MDA-MB-231). It supported the dose-depended delivery of curcumin on cancer cells [30].…”
Section: Introductionmentioning
confidence: 99%
“…5-flurouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles 4 showed a sustained release and enhanced anti-cancer effects both in vitro and in vivo [29]. Song et al, 2018 [30] reported the high uptake efficiency, toxicity, and sustained release in human Caucasian breast adenocarcinoma cells (MDA-MB-231). It supported the dose-depended delivery of curcumin on cancer cells [30].…”
Section: Introductionmentioning
confidence: 99%
“…Curcumin-loaded nanoparticles showed stronger cytotoxicity to the breast cancer cell line MDA-MB-231 than breast cancer cell HDF. Therapeutic performance of curcumin was improved as compared to the free drug [108]. Sorasitthiyanukarn et al also employed alginate/chitosan nanocomplexes to deliver curcumin diglutaric acid (a prodrug of curcumin) for cancer treatment.…”
Section: Albuminmentioning
confidence: 99%
“…Hyaluronic acid, chitosan Hyaluronic acid, chitosan, microRNA-34a, doxorubicin Achieved synergistic effects; reduced drug resistance and side effects of doxorubicin [106] Gelatin, albumin Gelatin, albumin, GNF-5837 Efficient cellular uptake; improved therapeutic efficacy of GNF-5837 [107] Alginate, chitosan Alginate, chitosan, curcumin, iron oxide Controllable release; targeted delivery with the aid of magnetic field; improved therapeutic performance of curcumin [108] Alginate, chitosan Alginate, chitosan, curcumin diglutaric acid Improved protection and controlled release; enhanced cellular uptake and anticancer activity [109] Hyaluronic acid, albumin hyaluronic acid, albumin, paclitaxel…”
Section: Composition Of Nanoparticles Encapsulation Advantagesmentioning
confidence: 99%
“…However, the poor oral bioavailability of curcumin limits its therapeutic efficacity [6,7]. In fact, its poor solubility in an aqueous medium and weak stability in alkaline pH conditions or gastrointestinal fluids restrict its availability to cross into the blood circulation by oral administration.…”
Section: Introductionmentioning
confidence: 99%